Search results for: RPL36 / Q9Y3U8


Search Results

EDRN Biomarkers:
FDA Biomarkers:
Disease Mutations:
Loading...
Differential Expression:


Healthy Expression:
Loading...
Mutation Literature Mining:
Expression Literature Mining:
Reactome:


Differential expression of various cancer types
More Info

thyroid cancercolorectal cancerhead and neck cancerbreast canceruterine cancerstomach cancerprostate canceresophageal cancerkidney cancerurinary bladder cancerlung cancerliver cancer020406080100
Down RegulatedUp RegulatedCancer TypesFrequency of Expression Trends

Please click BioXpress below to explore or download results.
Frequency of expression for each cancer type where red denotes down-regulation, and green denotes up-regulation.

Human Healthy Bulk RNA-seq Expression Overview
More Info

prostate glandthoracic mammary glandesophagusuterine cervixthyroid glandurinary bladderuterusstomachlungadult mammalian kidneyliverpancreas020406080100
Anatomical EntityExpression Level
Absent expression
Low expression
Medium expression
High expression

Please click Bgee below to explore or download results.
Healthy bulk RNA-seq for human tissue and the level at which genes are expressed. The silver squares denote absent expression levels, red denotes low expression, green denotes medium expression, and blue denotes high expression.

Mouse Normal Bulk RNA-seq Expression Overview
More Info

lungliverkidney020406080100
Anatomical EntityExpression Level
Absent
Low Exp Lvl
Medium Exp Lvl
High Exp Lvl
Healthy bulk RNA-seq for mouse tissue and the level at which genes are expressed. The silver squares denote absent expression levels, red denotes low expression, green denotes medium expression, and blue denotes high expression.

Mutation Frequencies by Cancer Type
More Info


Please click BioMuta below to explore or download results.
Mutation frequencies by cancer types

PEM scores across cell types for various cancers
More Info

H358LC-MBT-15LC-PT-45MGH26MGH28MGH29MGH30MGH31Lung cancerMalignant glioma−0.1−0.0500.050.10.15
Cancer Cell-typePreferential Expression Measure
High preference
Medium preference
Low preference
Cell-type marker gene
This chart displays preferential expression measure (PEM) scores and expression preference types across cancer cell-types for a given gene. PEM assessed the difference between observed and expected expression of a gene in a cell-type with the assumption that the given gene was uniformly expressed in all cell-types of a cancer-type.

Expression Literature mining across different cancers

hepatocellular carcinoma00.20.40.60.81
Up RegulatedDown RegulatedCancer TypesNumber of Evidences from Literature

Please click DEXTER below to explore or download results.
Expression literature evidence for the specific gene across different cancers. The green bars represent number of abstracts that mentions the up regulation of the gene while the red bar represent the down regulation of genes.

Percentage of Measured Glycan Intensities for Cirrhosis, HCC, and Transplant for RPL36 / Q9Y3U8

No HCC Glycan intensity measurements for this gene
Comparison of the average, normalized MALDI-MS intensity of 50 specific N-glycans for the specified protein in patients with cirrhosis, hepatocellular carcinoma (HCC), or a transplant.

Mutation Literature mining across different cancers

breast cancercervical cancer0510152025
Number of Evidences from Literature

Please click DiMeX below to explore or download results.
Mutation literature evidence derived from gene mentions in abstracts.

Biomarker Details

No EDRN Biomarkers for this gene


FDA approved biomarker information

Reactome pathways associated with gene

Mutation Details


Expression Details


Bgee Details


Dexter Details

DiMex Details